Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1?

J Nephrol. 2023 Mar;36(2):329-333. doi: 10.1007/s40620-022-01435-5. Epub 2022 Aug 20.
No abstract available

Keywords: Lumasiran; Primary hyperoxaluria type 1; RNA interference therapy.

MeSH terms

  • Humans
  • Hyperoxaluria*
  • Hyperoxaluria, Primary* / diagnosis
  • Hyperoxaluria, Primary* / therapy
  • Nephrologists

Substances

  • lumasiran

Supplementary concepts

  • Primary hyperoxaluria type 1